FDA agrees to review Moderna's mRNA flu vaccine
Digest more
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
Add Yahoo as a preferred source to see more of our stories on Google. RFK Jr. canceled $500 million of funding for research on mRNA vaccine technology. Anadolu/Getty Images At a Sept. 4, 2025, hearing before the Senate Finance Committee, Health and Human ...